BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30978940)

  • 1. Untargeted Metabolomics Study of the In Vitro Anti-Hepatoma Effect of Saikosaponin d in Combination with NRP-1 Knockdown.
    Lv Y; Hou X; Zhang Q; Li R; Xu L; Chen Y; Tian Y; Sun R; Zhang Z; Xu F
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30978940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saikosaponin-d increases the radiosensitivity of smmc-7721 hepatocellular carcinoma cells by adjusting the g0/g1 and g2/m checkpoints of the cell cycle.
    Wang BF; Dai ZJ; Wang XJ; Bai MH; Lin S; Ma HB; Wang YL; Song LQ; Ma XL; Zan Y; Min WL; Cheng YA
    BMC Complement Altern Med; 2013 Oct; 13():263. PubMed ID: 24119370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saikosaponin-D enhances radiosensitivity of hepatoma cells under hypoxic conditions by inhibiting hypoxia-inducible factor-1α.
    Wang BF; Wang XJ; Kang HF; Bai MH; Guan HT; Wang ZW; Zan Y; Song LQ; Min WL; Lin S; Cheng YA
    Cell Physiol Biochem; 2014; 33(1):37-51. PubMed ID: 24401554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saikosaponin D from Radix Bupleuri suppresses triple-negative breast cancer cell growth by targeting β-catenin signaling.
    Wang J; Qi H; Zhang X; Si W; Xu F; Hou T; Zhou H; Wang A; Li G; Liu Y; Fang Y; Piao HL; Liang X
    Biomed Pharmacother; 2018 Dec; 108():724-733. PubMed ID: 30248540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saikosaponin-d increases radiation-induced apoptosis of hepatoma cells by promoting autophagy via inhibiting mTOR phosphorylation.
    Wang B; Min W; Lin S; Song L; Yang P; Ma Q; Guo J
    Int J Med Sci; 2021; 18(6):1465-1473. PubMed ID: 33628104
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of SSd combined with radiation on inhibiting SMMC-7721 hepatoma cell growth.
    Wang BF; Lin S; Bai MH; Song LQ; Min WL; Wang M; Yang P; Ma HB; Wang XJ
    Med Sci Monit; 2014 Jul; 20():1340-4. PubMed ID: 25080219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saikosaponins and the deglycosylated metabolites exert liver meridian guiding effect through PXR/CYP3A4 inhibition.
    Liu Q; Xue Y; Liu J; Ren S; Xu J; Yang J; Xing Y; Zhang Z; Song R
    J Ethnopharmacol; 2021 Oct; 279():114344. PubMed ID: 34147617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of histological and metabolomic assessments to evaluate the potential pharmacological efficacy of saikosaponin D.
    Yang T; Li X; Wang X; Meng X; Zhang Z; Zhao M; Su R
    J Pharm Biomed Anal; 2024 May; 242():116001. PubMed ID: 38354536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of p53, nuclear factor kappaB and Fas/Fas ligand in induction of apoptosis and cell cycle arrest by saikosaponin d in human hepatoma cell lines.
    Hsu YL; Kuo PL; Chiang LC; Lin CC
    Cancer Lett; 2004 Sep; 213(2):213-21. PubMed ID: 15327837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of Saikosaponins-d on reversing malignant phenotype of HepG2 cells in vitro].
    Zhu BH; Pu R; Zhang GP; Li MY; Wang LT; Yuan JK
    Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):764-7. PubMed ID: 22409850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
    Li C; Guan X; Xue H; Wang P; Wang M; Gai X
    Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of saikosaponin-d on syndecan-2, matrix metalloproteinases and tissue inhibitor of metalloproteinases-2 in rats with hepatocellular carcinoma.
    Jia X; Dang S; Cheng Y; Zhang X; Li M; Li Y; Li S
    J Tradit Chin Med; 2012 Sep; 32(3):415-22. PubMed ID: 23297566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saikosaponin D: review on the antitumour effects, toxicity and pharmacokinetics.
    Zhou P; Shi W; He XY; Du QY; Wang F; Guo J
    Pharm Biol; 2021 Dec; 59(1):1480-1489. PubMed ID: 34714209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saikosaponin a and its epimer saikosaponin d exhibit anti-inflammatory activity by suppressing activation of NF-κB signaling pathway.
    Lu CN; Yuan ZG; Zhang XL; Yan R; Zhao YQ; Liao M; Chen JX
    Int Immunopharmacol; 2012 Sep; 14(1):121-6. PubMed ID: 22728095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saikosaponin D disrupts platelet-derived growth factor-β receptor/p38 pathway leading to mitochondrial apoptosis in human LO2 hepatocyte cells: a potential mechanism of hepatotoxicity.
    Chen L; Zhang F; Kong D; Zhu X; Chen W; Wang A; Zheng S
    Chem Biol Interact; 2013 Oct; 206(1):76-82. PubMed ID: 23994742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of saikosaponin-d on CYP3A4 in HepaRG cell and protein-ligand docking study.
    Li H; Tang Y; Wei W; Yin C; Tang F
    Basic Clin Pharmacol Toxicol; 2021 May; 128(5):661-668. PubMed ID: 33369126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Segetoside I, a plant-derived bisdesmosidic saponin, induces apoptosis in human hepatoma cells in vitro and inhibits tumor growth in vivo.
    Firempong CK; Zhang HY; Wang Y; Chen J; Cao X; Deng W; Zhou J; Wang Q; Tong SS; Yu J; Xu X
    Pharmacol Res; 2016 Aug; 110():101-110. PubMed ID: 27180010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomics Reveals the Efficacy of Caspase Inhibition for Saikosaponin D-Induced Hepatotoxicity.
    Zhang QQ; Huang WQ; Gao YQ; Han ZD; Zhang W; Zhang ZJ; Xu FG
    Front Pharmacol; 2018; 9():732. PubMed ID: 30034340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity and anti-hepatitis B virus activities of saikosaponins from Bupleurum species.
    Chiang LC; Ng LT; Liu LT; Shieh DE; Lin CC
    Planta Med; 2003 Aug; 69(8):705-9. PubMed ID: 14531019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saikosaponin D relieves unpredictable chronic mild stress induced depressive-like behavior in rats: involvement of HPA axis and hippocampal neurogenesis.
    Li HY; Zhao YH; Zeng MJ; Fang F; Li M; Qin TT; Ye LY; Li HW; Qu R; Ma SP
    Psychopharmacology (Berl); 2017 Nov; 234(22):3385-3394. PubMed ID: 28875366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.